Pompili, Maurizio
 Distribuzione geografica
Continente #
EU - Europa 8.258
NA - Nord America 7.122
AS - Asia 2.533
AF - Africa 46
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 14
Totale 18.027
Nazione #
US - Stati Uniti d'America 7.084
DE - Germania 3.181
SE - Svezia 1.638
CN - Cina 1.220
IT - Italia 806
UA - Ucraina 716
SG - Singapore 541
IE - Irlanda 501
FR - Francia 341
ID - Indonesia 295
GB - Regno Unito 259
FI - Finlandia 232
RU - Federazione Russa 202
TR - Turchia 176
PL - Polonia 151
IN - India 132
BE - Belgio 57
JP - Giappone 38
IR - Iran 37
CI - Costa d'Avorio 33
CZ - Repubblica Ceca 29
CA - Canada 25
NL - Olanda 25
HK - Hong Kong 23
RO - Romania 22
EU - Europa 21
CH - Svizzera 19
ES - Italia 19
VN - Vietnam 16
AU - Australia 12
BR - Brasile 12
IL - Israele 12
TW - Taiwan 11
AT - Austria 9
GR - Grecia 9
HU - Ungheria 9
BZ - Belize 7
CL - Cile 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 5
KR - Corea 5
TZ - Tanzania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DK - Danimarca 4
MD - Moldavia 4
PA - Panama 4
PE - Perù 4
EG - Egitto 3
MK - Macedonia 3
MY - Malesia 3
SY - Repubblica araba siriana 3
BG - Bulgaria 2
BY - Bielorussia 2
EC - Ecuador 2
HR - Croazia 2
IQ - Iraq 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RE - Reunion 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A1 - Anonimo 1
AL - Albania 1
BD - Bangladesh 1
CO - Colombia 1
EE - Estonia 1
IM - Isola di Man 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 18.027
Città #
Chandler 1.553
Ashburn 587
Dublin 496
Jacksonville 415
Singapore 399
San Mateo 328
Nanjing 303
Jakarta 292
New York 244
Ann Arbor 234
Wilmington 209
Nürnberg 207
Boston 204
Princeton 175
Dearborn 158
Izmir 155
Moscow 150
Milan 144
Marseille 137
Cattolica 136
Woodbridge 123
Rome 115
Warsaw 111
Houston 108
Nanchang 108
Chicago 100
Beijing 96
Seattle 90
Boardman 87
Los Angeles 84
Redwood City 84
Bremen 83
Fairfield 82
Helsinki 79
Munich 72
Shenyang 66
Lancaster 63
Zhengzhou 63
Brussels 57
Kunming 57
Lawrence 56
Hebei 53
Hangzhou 48
Norwalk 48
Changsha 46
University Park 42
Mountain View 40
Redmond 40
Tianjin 40
Pune 38
Kraków 37
Augusta 34
Abidjan 33
San Jose 30
Jiaxing 29
Jinan 28
Guangzhou 27
Leawood 27
Cambridge 23
Shanghai 22
Fremont 20
Brno 19
Detroit 18
Hefei 17
San Diego 17
Hong Kong 16
Kish 16
Madrid 16
Washington 16
Andover 15
London 15
Lanzhou 13
Paris 13
Santa Clara 13
Taizhou 13
Auburn Hills 12
Simi Valley 12
Amsterdam 11
Bologna 11
Changchun 11
Edinburgh 11
Toronto 11
Zurich 11
Hanoi 10
Las Vegas 10
San Francisco 10
Tokyo 10
Falls Church 9
Hounslow 9
Lappeenranta 9
Monza 9
Ningbo 9
Taipei 9
Buffalo 8
Busto Arsizio 8
Florence 8
Phoenix 8
Vienna 8
Belize City 7
Esslingen am Neckar 7
Totale 9.470
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 387
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 294
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives. 254
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 211
A phase II study of sunitinib in advanced hepatocellular carcinoma 204
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 179
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 178
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 159
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 158
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 154
Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver 153
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 150
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 148
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 143
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 143
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 143
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 139
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 137
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 133
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 132
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 130
recurrent acute hepatitis associated with use of cetrizine 125
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 125
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 122
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 122
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 120
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 116
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 116
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study 114
New signs and old applications of echo-color-Doppler should always be comapred to a gold-standard 110
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 110
[The treatment of hepatocellular carcinoma: an update] 105
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 105
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 104
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 102
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 102
Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma 101
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 101
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 99
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 98
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 98
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 98
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 98
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results 98
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 97
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 96
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 95
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 92
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 92
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 91
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? 91
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 91
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 91
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 90
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 90
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 90
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation 90
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 89
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 89
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 89
Liver transplantation in patients with alcoholic liver disease: A retrospective study 89
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 88
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 88
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 88
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 87
[Liver transplantation] 84
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features 84
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 81
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 78
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 78
HEPATOCATT STUDY GROUP. Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging. 78
A case of variant angina in a patient under chronic treatment with sorafenib 77
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 77
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 77
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 76
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 76
Is coeliac disease a confounding factor in the diagnosis of NASH? 75
Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group 75
Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art 75
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 74
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 74
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 73
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 73
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 73
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography 73
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 73
Sarilumab use in severe SARS-CoV-2 pneumonia 73
Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax 72
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 72
Gastric emptying rate and hormonal response in type II diabetics 71
Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease 71
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 71
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 71
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 71
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. 71
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 70
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 70
Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers 69
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 68
Bridge treatments of hepatocellular carcinoma in cirrhotic patients submitted to liver transplantation 67
Totale 10.712
Categoria #
all - tutte 83.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.511 0 0 0 102 178 246 227 101 152 135 194 176
2020/20211.564 98 170 16 149 194 58 156 24 228 92 317 62
2021/20222.119 143 170 38 128 130 55 43 316 76 156 391 473
2022/20234.691 620 587 386 663 297 560 246 398 526 101 189 118
2023/20242.506 116 692 95 120 114 375 133 92 29 156 230 354
2024/2025857 131 133 473 120 0 0 0 0 0 0 0 0
Totale 18.350